Journal
ENDOCRINOLOGY
Volume 160, Issue 8, Pages 1811-1820Publisher
ENDOCRINE SOC
DOI: 10.1210/en.2019-00097
Keywords
-
Categories
Funding
- Department of Defense Grant [W81XWH-16-1-0297]
- National Cancer Institute [1K22CA207578, P30CA016056]
- Susan G. Komen Grant [CCR18547413]
Ask authors/readers for more resources
Cancer recurrence and metastasis involves many biological interactions, such as genetic, transcription, environmental, endocrine signaling, and metabolism. These interactions add a complex understanding of cancer recurrence and metastatic progression, delaying the advancement in therapeutic opportunities. We highlight the recent advances on the molecular complexities of endocrine-related cancers, focusing on breast and prostate cancer, and briefly review how endocrine signaling and metabolic programs can influence transcriptional complexes for metastasis competence. Nuclear receptors and transcriptional coregulators function as molecular nodes for the crosstalk between endocrine signaling and metabolism that alter downstream gene expression important for tumor progression and metastasis. This exciting regulatory axis may provide insights to the development of cancer therapeutics important for these desensitized endocrine-dependent cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available